10-Q: DSwiss Inc. Reports Strong Revenue Growth in Q3 2024, Despite Net Loss
Quarterly Report
DSwiss Inc. saw a significant increase in revenue for the third quarter of 2024 compared to the same period last year, but still reported a net loss for the quarter.
Summary
- DSwiss Inc. reported a substantial increase in revenue for the three and nine months ended September 30, 2024, compared to the same periods in 2023.
- Revenue for the three months ended September 30, 2024, was $1,027,198, compared to $425,569 in 2023.
- Revenue for the nine months ended September 30, 2024, reached $2,077,942, up from $1,046,764 in 2023.
- Gross profit for the three months ended September 30, 2024, was $113,201, while for the nine months it was $515,271.
- The company experienced a net loss of $61,468 for the three months ended September 30, 2024, but a net profit of $137,343 for the nine months ended September 30, 2024.
- Cash and cash equivalents increased to $473,250 as of September 30, 2024, compared to $288,932 in 2023.
- The company's working capital is significant and expected to meet basic operating requirements for approximately twelve months.
- The company identified material weaknesses in internal control over financial reporting.
Sentiment
Score: 6
Explanation: The document shows strong revenue growth and a positive net profit for the nine-month period, but is tempered by a net loss for the quarter, material weaknesses in internal controls, and going concern risks. The overall sentiment is cautiously optimistic.
Positives
- The company has demonstrated strong revenue growth in both the three and nine month periods.
- The company has improved its gross profit for the nine month period.
- The company has improved its net profit for the nine month period.
- The company has a positive operating cash flow.
- The company has increased its cash and cash equivalents.
Negatives
- The company reported a net loss for the three months ended September 30, 2024.
- The company has identified material weaknesses in internal control over financial reporting.
- The company has an accumulated deficit of $1,272,810 as of September 30, 2024.
- The company's ability to continue as a going concern is dependent on improving profitability and financial support from shareholders.
Risks
- The company's ability to continue as a going concern is dependent on improving its profitability and the continuing financial support from its shareholders.
- There are material weaknesses in the company's internal control over financial reporting.
- The company is exposed to credit risk from accounts receivables.
- The company is exposed to exchange rate risk due to its international operations.
- The company relies on a few major customers and vendors, creating concentration risk.
Future Outlook
The company expects its current capital resources to meet its basic operating requirements for approximately twelve months and plans to expand through social media marketing and strategic partnerships.
Management Comments
- Management believes the existing shareholders or external financing will provide the additional cash to meet the Company's obligations as they become due.
- Management is focused on talent development, product research and development, and providing OEM and ODM services.
- Management intends to primarily utilize social media to reach customers and expand brand awareness.
Industry Context
The company operates in the growing nutraceutical and skincare industry, focusing on private label manufacturing services. The company is leveraging social media marketing, which is a common strategy in the industry to reach customers directly.
Comparison to Industry Standards
- The company's gross margins may not be directly comparable to other entities as they do not include all distribution costs in cost of revenue.
- The company's revenue growth is strong compared to the previous year, indicating a positive trend in the market.
- The company's focus on OEM/ODM services is a common business model in the nutraceutical and skincare industry.
- The company's reliance on social media marketing is consistent with industry trends for reaching customers directly.
Related Party Transactions
- The company had related party transactions for professional fees, sales, and purchases.
- Related party A is a wholly owned subsidiary of a 7.33% shareholder of the company.
- Related party B's director is the founder of the company.
Stakeholder Impact
- Shareholders may be concerned about the net loss for the quarter and the material weaknesses in internal control.
- Employees may be impacted by the company's financial performance and any potential restructuring.
- Customers may benefit from the company's continued product development and expansion.
- Suppliers may be impacted by the company's financial performance and any changes in purchasing.
Next Steps
- The company plans to continue implementing its social media marketing strategy.
- The company plans to form partnerships with local companies in various countries to expand its global reach.
- The company needs to address the material weaknesses in internal control over financial reporting.
Key Dates
| Date | Description |
|---|---|
| 2011-03-10 | DSwiss Sdn Bhd incorporated in Malaysia. |
| 2015-05-28 | DSwiss, Inc. incorporated in Nevada and DSwiss Holding Limited and DSwiss (HK) Limited incorporated. |
| 2015-08-31 | DSwiss, Inc. restructured to be the holding company parent to DSwiss Holding Limited. |
| 2016-03-17 | DSwiss Biotech Sdn Bhd incorporated in Malaysia. |
| 2018-07-31 | First finance lease agreement commenced. |
| 2019-11-01 | Company adopted ASC 842, Leases. |
| 2021-12-03 | Second finance lease agreement commenced. |
| 2023-01-18 | DSwiss (HK) Limited acquired 60% equity interest in DSwiss Biotech Sdn. Bhd. |
| 2024-09-30 | End of the reporting period for the quarterly report. |
| 2024-11-14 | Date of the quarterly report filing. |
Keywords
biotech, nutraceutical, skincare, OEM, ODM, revenue, profit, financial results, internal control, Malaysia, ASEAN
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.